argus

Ind-Swift Laboratories Ltd.

NSE: INDSWFTLABINE915B010193,204 Cr

Timeline

Time (IST)TypeMEventSrc
22 Apr, 03:38 pmInd-Swift Laboratories Ltd - 532305 - Disclosures Under Regulation 29(2) Of The SEBI (Substantial Acquisition Of Shares And Takeover) Regulations, 2011bse
21 Apr, 05:13 pmInd-Swift Laboratories Ltd - 532305 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011bse
13 Apr, 06:21 pmSignificant increase in volume has been observed in Ind-Swift Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Ind-Swift Laboratories Limited has submitted their response.nse
09 Apr, 01:51 pmInd-Swift Laboratories Ltd - 532305 - Clarification sought from Ind-Swift Laboratories Ltdbse
08 Apr, 07:12 pmSignificant increase in volume has been observed in Ind-Swift Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.nse
07 Apr, 05:29 pmInd-Swift Laboratories Limited has informed the Exchange about Receipt of Arbitration Awardnse
27 Mar, 07:04 pmInd-Swift Laboratories Limited has informed the Exchange regarding Outcome of Board Meeting held on March 27, 2026.nse
02 Mar, 06:00 pmIntimation regarding EcoVadis Silver Medal and Global Certificationnse
01 Mar, 08:09 pmInd-Swift Laboratories Limited has informed regarding Lapse of 65,00,000 Fully Convertible Warrants and Forfeiture of Upfront Amountnse
27 Feb, 11:58 amDisclosure under Regulation 30 of the SEBI (Listing Obligations and DisclosureRequirements) Regulations, 2015nse
27 Feb, 10:00 amInd-Swift Laboratories Ltd - 532305 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011bse
24 Feb, 06:15 pmInd-Swift Laboratories Limited has informed the Exchange about Conversionnse
24 Feb, 06:06 pmInd-Swift Laboratories Ltd - 532305 - Announcement under Regulation 30 (LODR)-Conversion of Securitiesbse
16 Feb, 01:44 pmInd-Swift Laboratories Limited has informed the Exchange regarding a press release dated February 16, 2026, titled "IND-SWIFT LABORATORIES LIMITED TO UPGRADE SAMBA FACILITY WITH AN INVESTMENT OF ₹400 MILLION FOR EU-GMP & PIC/S COMPLIANCE; STRENGTHEN GLOBAL EXPORT STRATEGY".nse
16 Feb, 01:41 pmInd-Swift Laboratories Ltd - 532305 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
04 Feb, 06:48 pmInd-Swift Laboratories Limited has informed the Exchange about Investor Presentationnse
04 Feb, 06:44 pmInd-Swift Laboratories Ltd - 532305 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
03 Feb, 03:58 pmMONITORING AGENCY REPORT FOR THE QUARTER ENDED 31ST DECEMBER 2025 FOR FUNDS RAISED THROUGH PREFERENTIAL ISSUEnse
03 Feb, 03:48 pmInd-Swift Laboratories Ltd - 532305 - Announcement under Regulation 30 (LODR)-Monitoring Agency Reportbse
02 Feb, 05:23 pmIntimation of Schedule of Analysts / Institutional Investors Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015nse
31 Jan, 08:39 pmInd-Swift Laboratories Ltd - 532305 - Statement Of NIL Deviation For The Quarter Ended December 31, 2025bse
31 Jan, 08:27 pmInd-Swift Laboratories Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32nse
31 Jan, 07:10 pmInd-Swift Laboratories Ltd - 532305 - Financial Results For The Quarter Ended December 31, 2025 On Standalone And Consolidated Basis.bse
31 Jan, 06:54 pmInd-Swift Laboratories Limited has submitted to the Exchange, the Outcome of the Board Meeting held on January 31, 2026nse
28 Jan, 05:43 pmInd-Swift Laboratories Ltd - 532305 - Board Meeting Intimation for Meeting Of The Board Of Directors Scheduled To Be Held On January 31, 2026.bse
20 Jan, 06:34 pmIntimation of Schedule of Analysts / Institutional Investors Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015nse
14 Jan, 06:47 pmInd-Swift Laboratories Limited has informed the Exchange about Investor Presentationnse
14 Jan, 06:37 pmInd-Swift Laboratories Ltd - 532305 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
18 Dec, 02:18 pmDisclosure under Regulation 10(6)- Report to Stock Exchanges in respect of acquisition made in reliance upon exemption provided for in Regulation 10 of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 for inter-se transfer of shares between the promoters of the Companynse
18 Dec, 09:51 amInd-Swift Laboratories Ltd - 532305 - Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011bse
17 Dec, 07:55 pmRishav Mehta has submitted to the Exchange a copy of Disclosures under Regulation 10(6)-Report to stock Exchange in respect of any acquisition made in reliance upon exemption provided for in regulation 10 of SEBI (SAST) Regulations, 2011nse
15 Dec, 06:33 pmReceipt of Good Manufacturing Practice (GMP) certificate from National Center for Public Health and Pharmacy (NNGYK-Hungary).nse
08 Dec, 06:30 pmInd-Swift Laboratories Ltd - 532305 - Announcement under Regulation 30 (LODR)-Change in Managementbse
08 Dec, 06:22 pmIntimation for appointment of Senior Management Personnelnse
05 Dec, 12:20 pmIntimation of trading approval obtained from Stock Exchanges for 81,24,698 Equity Shares of RS. 10/- each issued pursuant to the approved Scheme of Amalgamationnse
21 Nov, 03:45 pmIntimation regarding receipt of ISO 14001:2015 and ISO 45001:2018 Certificationsnse
14 Nov, 07:13 pmMonitoring Agency report for the Quarter ended September 30, 2025 in respect to fund raised through Preferential Issue.nse
14 Nov, 07:11 pmInd-Swift Laboratories Ltd - 532305 - Announcement under Regulation 30 (LODR)-Monitoring Agency Reportbse
14 Nov, 07:00 pmInd-Swift Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.nse
14 Nov, 06:56 pmInd-Swift Laboratories Ltd - 532305 - Board Meeting Outcome for Approval Of Un-Audited Financial Results For The Quarter And Half Year Ended September 30, 2025bse
07 Nov, 05:56 pmInd-Swift Laboratories Ltd - 532305 - Board Meeting Intimation for Meeting To Be Held On 14/11/2025bse
04 Nov, 06:05 pmInd-Swift Laboratories Limited has informed the Exchange regarding 'UPDATE ON LISTING OF SHARES ALLOTTED PURSUANT TO THE SCHEME OF AMALGAMATION'.nse
29 Sept, 06:18 pmDisclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.nse
12 Sept, 05:51 pmIntimation regarding Outcome of the meeting of Investment Committee of the Board.nse
10 Sept, 05:46 pmInd-Swift Laboratories Limited has informed the Exchange regarding 'Disclosure under Regulation 10(6)- Report to Stock Exchanges in respect of acquisition made in reliance upon exemption provided for in Regulation 10 of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 for inter-se transfer of shares between the promoters of the Company '.nse
09 Sept, 05:47 pmInd-Swift Laboratories Limited has informed the Exchange about General Updatesnse
09 Sept, 05:16 pmInd-Swift Laboratories Ltd - 532305 - Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011bse
05 Sept, 10:11 pmInd-Swift Laboratories Ltd - 532305 - Reg. 34 (1) Annual Report.bse
01 Sept, 08:28 pmInd-Swift Laboratories Limited has informed the Exchange regarding Book Closure pursuant to Regulation 42 of SEBI (LODR) Regulations, 2015.nse
01 Sept, 08:21 pmINTIMATION OF ANNUAL GENERAL MEETING, E-VOTING AND BOOK CLOSURE FOR THE FINANCIAL YEAR 2024-25.nse